Considering the strong links between invasiveness and EMT and the fundamental role of invasiveness in metastasis of cancer cells, our findings suggest that reducing these genes in our SDCs population after SMAD4 inhibition may offer new therapeutic approaches for RCC. This evidence concerns the gene SMAD4 and renal cell carcinoma.